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Membrane diffusions are known to form homo-and heteromers at the plasma membrane, but the
molecular properties of these oligomers are relatively unknown. Here, we show a method that allows the
diffusion of G protein-coupled receptors oligomers in the plasma membrane to be monitored in single cells
by combining Bimolecular Fluorescence Complementation and Fluorescence Correlation Spectroscopy. With
this approach we have measured, for the ﬁrst time, the membrane diffusional characteristics of adenosine A1
and A2A receptor homo-and heterodimers in Chinese Hamster Ovary cells. Interestingly, both homodimers
display similar diffusion co-efﬁcients (D) when expressed in living cells (D=5.0 and 4.8×10−9 cm2/s,
respectively) but the heterodimer formed by these receptors exhibit a signiﬁcantly faster plasma membrane
diffusion co-efﬁcent (D=5.6×10−9 cm2/s) when compared to the adenosine A1 receptor tagged with the full-
length yellow ﬂuorescent protein (D=4.0×10−9 cm2/s). Overall, these results demonstrate differences in
plasma membrane diffusion between adenosine receptor homo-and heterodimers, providing new insights
into the molecular plasticity of G protein-coupled receptor oligomerization.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionAdenosine, a well known neuromodulator, exerts its actions
through G protein-coupled adenosine receptors (GPCRs). Of the four
known adenosine receptors (A1, A2A, A2B and A3), the adenosine A1 and
A2A receptors (A1R and A2AR, respectively) are the major mediators of
the central effects of adenosine [1]. The most abundant and homo-
geneously distributed adenosine receptor in the brain is the A1R,which
is functionally coupled to members of the pertussis toxin-sensitive
family of Gproteins (Gi1, Gi2, Gi3 andGo) andwhose activation regulates
several membrane and intracellular proteins such as adenylyl cyclase,
Ca2+ channels, K+ channels and phospholipase C [2]. The A2AR is
expressed at high levels in only a few regions of the brain, primarily
striatum, olfactory tubercle and the nucleus accumbens [3]. A2ARs are
predominantly coupled to Gs/Golf proteins [4], thus activating adenylyl
cyclase. Although A2ARs can also signal through other means such as
the mitogen-activated protein kinase (MAPK) cascade, via a pathway
that is independent of heterotrimeric G proteins [5,6].
The fact that GPCRs form functional homo- and heteromers, or
even highly ordered oligomers, is now generally accepted, although
their functional signiﬁcance is less clear. It is possible however that
understanding their properties may open new avenues for drug035820; fax: +34 934029082.
l rights reserved.discovery [7]. Evidence of such receptor-receptor interactions was
initially obtained from co-immunoprecipitation and immobilized
protein-protein interaction assays [8,9]. However, the invasive nature
of such methods has the disadvantage of altering the natural state of
the cell and therefore may not represent its real structure. More
recently, light resonance energy transfer-based methods have been
used in the study of G protein-coupled receptor oligomerization [9].
These approaches, including Bioluminescence and Fluorescence
Resonance Energy Transfer (BRET/FRET) techniques, have the advan-
tage that most of the protein-protein interactions determined are
assessed in living cells, thus maintaining the physiological environ-
ment and allowing real time measurements. In spite of the large
amount of information accumulated on GPCR oligomerization none of
the approaches used can detect individual molecular differences
between the diverse receptor species detected (e.g. homo- vs.
heterodimers).
The protein fragment complementation methods [10] in general
and the Bimolecular Fluorescence Complementation (BiFC) approach
[11] in particular have been used for the visualization of interactions
between many different proteins in a wide variety of cell types and
organisms [12]. This ﬂuorophore-based method, largely used in the
ﬁeld of plant sciences [13], enables direct visualization of protein
interactions in living cells [11] and is likely to develop into a standard
technique for the identiﬁcation, veriﬁcation and detailed character-
ization of protein-protein interactions.
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uses laser light focussed to a diffraction-limited spot in conjunction
with confocal optics to create a small deﬁned detection element
(∼0.2 ﬂ). Diffusion of a ﬂuorescent species within this element
results in time-dependent ﬂuctuations in the detected ﬂuorescence.
These ﬂuctuations can be analysed by autocorrelation analysis to
yield quantitative information about the diffusion and concentra-
tion of ﬂuorescent species within that volume. This technique has
now been successfully applied to measure the diffusion co-
efﬁcients of a number of tagged membrane proteins in living
cells, including those of GPCRs [14]. FCS can be applied to living
cells, has high resolution (∼0.1 μm2 of membrane), and can
approach single molecule sensitivity. This is particularly important,
since it allows even artiﬁcially expressed receptors to be studied at
low levels of expression. Combining the BiFC approach with FCS
therefore provides a unique opportunity to exclusively study the
membrane behaviour of GPCR oligomers in small areas of cell
membrane.
The A1R and A2AR, both class A GPCRs, and which have been shown
to exist in cell membranes as homo-and heteromers [15–17],
constitute an archetypal model for molecular homo-and heteromeric
studies. In the present study we have used a combination of BiFC and
FCS techniques to monitor speciﬁcally the diffusional properties of
adenosine receptor homo-and heterodimers in the plasmamembrane.
Interestingly, our results demonstrate differences in the plasma
membrane diffusion properties between homo-and heterodimers of
these receptors. This may provide some indication that heterodimers
show a different membrane localisation or protein conformation
within the lipid bilayer than homodimers.
2. Materials and methods
2.1. Plasmid constructs
Full-length yellow ﬂuorescence protein (YFP) was subcloned in the
XhoI site of pcDNA3.1 vector (Invitrogen, Carlsbad, CA, U.S.A.). A C-
terminal truncated version of YFP, named N-YFP (amino acids 1 to
155), was made by PCR ampliﬁcation and cloning into the XhoI site of
pcDNA3.1 using the following primers: FnYFP (5′-CCGCTCGAGAC-
CATGGTGAGCAAGGGCGAGGAGC-3′) and RnYFP (5′-CCGTCTAGAT-
CAGGCCATGATATAGACGTTG-3′). Also, a N-terminal truncated
version of YFP, named C-YFP (amino acids 155 to 231), was made
using the same strategy and using the following primers: FcYFP (5′-
CCGCTCGAGACCATGGACAAGCAGAAGAACGGC-3′) and RcYFP (5′-
CCGTCTAGATTACTTGTACAGCTCGTCCAT-3′). The cDNAs encoding the
human CD4, human A1R and human A2AR were subcloned into
pcDNA3.1 containing YFP constructs, thus containing in frame the
sequences for YFP, N-YFP or C-YFP.
2.2. Cell culture, transfection and confocal microscopy
Chinese hamster ovary (CHO-K1) cells were grown in Dulbecco's
modiﬁed Eagle'smedium, DMEM (Sigma-Aldrich, St. Louis, MO, U.S.A.)
supplementedwith 1mM sodium pyruvate, 2 mM L-glutamine,100 U/
ml streptomycin, 100 μg/ml penicillin and 10% (v/v) foetal bovine
serum (FBS) at 37 °C and in an atmosphere of 5% CO2. CHO-K1 cells
growing in 25 cm3 dishes containing 20 mm coverslips were
transiently transfected with DNA encoding for the proteins speciﬁed
in each case by Lipofectamine (Invitrogen). The cells were harvested at
either 24 or 48 h after transfection.
Transiently transfected CHO-K1 cells were ﬁxed in 1% paraformal-
dehyde for 10 min, and washed with phosphate buffered saline (PBS)
containing 20 mM glycine to quench the remaining free aldehyde
groups. Cells on coverslips were mounted with Vectashield immuno-
ﬂuorescence medium (Vector Laboratories, Peterborough, U.K.).
Microscope observations were made with an Olympus Fluoview 500confocal scanning laser adapted to an inverted Olympus IX-70
microscope.
2.3. Membrane preparation, gel electrophoresis and immunoblotting
CHO-K1 cells were harvested at either 24 or 48 h after transfection.
Membrane suspensions from transfected CHO-K1 cells were obtained
as described previously [18]. Sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS/PAGE) was performed using 7.5 or 10%
polyacrylamide gels. Proteins were transferred to PVDF membranes
using a semi-dry transfer system and immunoblotted with a rabbit
anti-A1R polyclonal antibody (1:1000; Afﬁnity BioReagents, Golden,
CO, U.S.A.) or a mouse anti-A2AR monoclonal antibody (clone 7F6-G5-
A2; 1:1000; UpState, Charlottesville, VA, U.S.A.) and then a horse-
radish-peroxidase (HRP)-conjugated goat anti-rabbit IgG (1:30,000;
Pierce, Rockford, IL, U.S.A.) or a horseradish-peroxidase (HRP)-
conjugated goat anti-mouse IgG (1:30,000; Pierce). The immunor-
eactive bands were developed using a chemiluminescent detection kit
(Pierce) [19].
2.4. cAMP measurements
Transfected CHO-K1 cells (3×106 cell/sample) were incubated
overnight in serum-free DMEM in the presence of 0.5 U/ml adenosine
deaminase (ADA, EC 3.5.4.4; Roche, Basel, Switzerland). Before agonist
challenge, cells were preincubated with 50 μM zardaverine (Sigma-
Aldrich) for 10 min and then stimulated with the indicated concentra-
tion of forskolin (Ascent Scientiﬁc, Weston-Super-Mare, U.K.), R-PIA
(Sigma-Aldrich), CGS21680 (Tocris, Bristol, U.K.) or vehicle for another
10 min. After perchloric acid precipitation and potassium hydroxide
neutralization the accumulated cAMPwas measured by an Amersham
[3H]cyclic AMP assay system (GE Healthcare, Buckinhamshire, U.K.) as
described in the manufacture's manual. Brieﬂy, 50 μl of cAMP stan-
dards or neutralized samples were displayed in duplicate in assays
tubes. Then 50 μl of 1 pM [3H]cAMP were added together with 100 ml
of binding protein (cAMP soluble receptor) and incubated for 180 min
at 4 °C. At the end of the incubation, 100 ml of charcoal was added
and tubes were shaken and centrifuged at 12,000 ×g for 6 min. Two
hundred microliter of supernatant were counted in a Wallac 1409
liquid scintillation spectrometer with 50% efﬁciency. A standard curve
(1–16 pmol) was constructed with known concentrations of cAMP for
each experiment. The speciﬁc cAMP generation in each case was de-
termined bycalculating the difference between the cAMPaccumulated
in the stimulated vs. the non-stimulated transfected cells.
2.5. Fluorescence correlation spectroscopy
CHO-K1 cells were grown to 70% conﬂuency in 8-well Labtek
plates (Nunc Nalgene, Rochester, NY, U.S.A.) in phenol red free DMEM-
F12 (Sigma) medium supplemented with 10% FCS and 2 mM
glutamine. Cells were transfected for 24 h with a total of 0.15 mg/
well of DNA using Lipofectamine according to manufacturer's
instructions. Cells were then incubated for a further 24 h at 30 °C in
a humidiﬁed atmosphere of 5%CO2. Cells were washed and allowed to
equilibrate in HEPES-buffered saline solution, before FCS measure-
ments were performed on the upper cell membrane on a modiﬁed
Confocor 2 system, as previously described [20]. Brieﬂy, the volume
was positioned in x–y using a live image from an Axiocam HR camera.
Cells were chosen at a ﬁxed camera exposure to ensure as far as
possible a similar expression level in each measurement. Subsequent
z-scanning allowed positioning of the volume on the upper mem-
brane, where FCS readings were taken for 30 s following a 15 s pre-
bleach. Readings were taken using 514 nm excitation, at the same
power (0.3 kW/cm2) in all experiments. Data were ﬁtted in Zeiss
AIM4.2 software, assuming two 2D diffusion components with a
separate pre-exponential term added to account for blinking of the
Fig. 2. cAMP accumulation. (A) Mock transfected cells or transiently expressing A1Rwt,
A1RYFP, A1RN-YFP and A1RC-YFP were preincubated overnight with 0.5 U/ml adenosine
deaminase and stimulated for 10 minwith 10 mM forskolin in the presence of 50 nM R-
PIA or vehicle and the speciﬁc cAMP accumulation was determined (see Materials and
methods). The receptor activity is expressed as a percentage of forskolin-induced cAMP
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measured in 3–4 independent transfections. Statistical analysis was by
one way ANOVA, with post-hoc Neuman–Keul's test, with Pb0.05
taken to indicate statistical signiﬁcance.
3. Results
3.1. Expression of adenosine receptor fusion proteins
The fusion proteins A1RYFP, A1RN-YFP, A1RC-YFP, A2ARYFP, A2ARN-YFP
and A2ARC-YFP together with the A1Rwt and A2ARwt were transiently
transfected into CHO-K1 cells. As shown in Fig. 1 the constructs
displayed the expected molecular size as determined by immunoblot-
ting. Brieﬂy, the rabbit anti-A1R antibody immunodetected a number
of bands of ∼38 kDa in extracts from CHO-K1 cells transiently
transfected with the human A1Rwt (Fig. 1A, lane 2), probably
representing different glycosylation states of the A1R, as has been
previously described [21]. This band did not appear in extracts ofmock
transfected cells (Fig. 1A, lane 1). On the other hand, the same
antibody detected a band of ∼65 kDa, ∼56 kDa and ∼48 kDa in
extracts from CHO-K1 cells transiently transfected with A1RYFP, A1RN-YFP
and A1RC-YFP, respectively (Fig. 1A, lane 3, 4 and 5). Similarly, the mouse
anti-A2AR antibody immunodetected a band of∼42 kDa in extracts from
CHO-K1 cells transiently transfected with the human A2ARwt (Fig. 1B,
lane 2) and a band of ∼69 kDa, ∼60 kDa and ∼ 52 kDa in extracts from
cells expressing A2ARYFP, A2ARN-YFP and A2ARC-YFP, respectively (Fig. 1B,
lane 3, 4 and 5).
To validate the functionality of A1R and A2AR constructs, we tested
their signalling capability. As mentioned above, these receptors byFig. 1. Expression of adenosine receptor fusion proteins. (A) Immunoblot detection of
A1R fusion proteins in CHO-K1 cells. Mock transfected cells (lane 1) or transiently
expressing A1Rwt (lane 2), A1RYFP (lane 3), A1RN-YFP (lane 4) and A1RC-YFP (lane 5) were
washed and membranes processed for immunoblotting (see Materials and methods).
Samples were analyzed by SDS-PAGE and immunoblotted using a rabbit anti-A1R as a
primary antibody and horseradish-peroxidase (HRP)-conjugated goat anti-rabbit IgG
(1/30000) as a secondary antibody. (B) Immunoblot detection of A2AR fusion proteins in
CHO-K1 cells. Mock transfected cells (lane 1) or transiently expressing A2ARwt (lane 2),
A2ARYFP (lane 3), A2ARN-YFP (lane 4) and A2ARC-YFP (lane 5) were processed as described
before. Samples were analyzed by SDS-PAGE and immunoblotted using a mouse anti-
A2AR as a primary antibody and horseradish-peroxidase (HRP)-conjugated goat anti-
mouse IgG (1/30000) as a secondary antibody.
accumulation taking as a reference themock transfected cells. (B) Mock transfected cells
or transiently expressing A2ARwt, A2ARYFP, A2ARN-YFP and A2ARC-YFP were preincubated
overnight with 0.5 U/ml adenosine deaminase and stimulated for 10 min with vehicle,
10 mM forskolin (F) or 200 nM CGS21680 (CGS) and the speciﬁc cAMP accumulation
was determined (see Materials and methods). The results are expressed as means ± SD
of three independent experiments performed in duplicate.means of G proteins activation are able to inhibit or activate adenylyl
cyclase, thus decreasing or increasing the intracellular levels of cAMP.
In CHO-K1 cells transiently expressing A1R constructs, agonist
challenge (50 nM of R-PIA) induced a signiﬁcant and comparable
decrease in forskolin-induced cAMP accumulation in all the constructs
tested when compared to the mock transfected cells (Fig. 2A).
Similarly, in cells expressing A2AR constructs the treatment with
200 nM of CGS21680 induced a signiﬁcant and comparable increase in
cAMP accumulation in all the constructs tested (Fig. 2B). Overall, these
results indicate that these adenosine receptor constructs are still
functional, even with besides the C-terminal tag introduced.
3.2. Homo-and heterodimerization of adenosine receptors determined by
BiFC
Adenosine receptor homo-and heterodimerization has been
characterized by several methodological approaches, including FRET
and BRET [15–17]. Here, by means of a BiFC approach we tested the
ability of adenosine receptors to form homo-and heterodimers by
producing a ﬂuorescent complex from non-ﬂuorescent constituents.
To this end, we generated receptor fusion proteins which contain C-
terminal fusions of either full-length YFP or the C-YFP and N-YFP
fragments and transfected them into CHO-K1 cells. Interestingly, after
24–48 h post-transfection we were able to visualize ﬂuorescence in
each case, indicating that YFP reconstitution had taken place. This was
predominantly on the cell membrane, although some intracellular
ﬂuorescence was observed, particularly in the case of the A2AR
homodimer. This indicated the formation of both A1R and A2AR homo-
and heterodimers in living cells (Fig. 3). When cells were transfected
with single constructs containing receptors fused to either C-YFP or N-
Fig. 3. Visualization of YFP-tagged adenosine receptors. CHO-K1 cells were transiently
transfected with the cDNA encoding YFP (A), A1RYFP (B), A1RN-YFP plus A1RC-YFP (C),
A2ARYFP (D), A2ARN-YFP plus A2ARC-YFP (E) and A1RN-YFP plus A2ARC-YFP (F) and processed
for confocal microscopy imaging. Microscope observations were made as described in
Materials and methods. A schematic representation illustrating YFP, A1RYFP, A1RN-YFP
plus A1RC-YFP, A2ARYFP, A2ARN-YFP plus A2ARC-YFP and A1RN-YFP plus A2ARC-YFP constructs is
shown on the left. Scale bar: 10 mm.
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their own are not ﬂuorescent (data not shown). It is important to note
that the subcellular distribution of receptor-complemented YFP, for
instance homo-and heterodimers, wasn't apparently different from
receptors labelled with full-length YFP, suggesting that there are nodifferences in the subcellular distribution of the diverse receptor
species (e.g. monomers vs. homo-and heterodimers).
It has been previously shown that ﬂuorescent protein fragments
are able to complement with low efﬁciency, thus forming ﬂuorescent
complexes, even in the absence of a speciﬁc interaction [11]. To ensure
that receptor homo-and heteromerization was not driven by sponta-
neous YFP complementation we designed a set of controls. The most
appropriate negative controls for this technique are fusion proteins
that are expressed in the same subcellular compartment, and are
similar to the protein being studied, but that are not able to interact
with it. In this study we have used two negative controls, namely the
human CD4 and human GABAB2 receptors, both used previously as a
negative control in GPCR oligomerization-BRET experiments [22]. To
this end, we generated CD4 and GABAB2 receptor BiFC fusion proteins
containing either C-YFP or N-YFP at their C-terminus (i.e. similar to
those produced for the two adenosine receptors). Under the same
experimental conditions to those used to demonstrate adenosine
receptor dimerization, we were not able to detect ﬂuorescence
complementation between any combinations of A1R or A2AR with
either CD4 or GABAB2 receptors. Furthermore, CD4 or GABAB2 receptor
themselves did form homodimers (data not shown). This strongly
support the idea that the adenosine receptor homo-and heterdimer-
ization represents a speciﬁc behaviour of these receptors, a fact
previously corroborated by using other approaches [15-17].
3.3. Plasma membrane diffusion of adenosine receptors as determined by
FCS
FCS is a powerful method for monitoring protein diffusion based
on the analysis of intensity ﬂuctuations from ﬂuorescent protein
conjugates at low (nM) concentration in a small detection volume
(approximately 0.25 ﬂ) [14,23]. This technique has been successfully
used to measure both the membrane diffusion of a Topaz tagged A1R,
as well as the interaction of a ﬂuorescent ligands with the A1R and
A3R [20,24] . Thus, by using the BiFC-based approach in combination
with FCS we were able to measure the plasma membrane diffusion
characteristics of A1R and A2AR homo-and heterodimers in the
membranes of living CHO-K1 cells. FCS offers two particular
advantages for this approach. Firstly, its high sensitivity means that
measurements can be obtained at the low expression levels used in
these experiments. Secondly, the small measurement volume allows
speciﬁc localisation of the measurement to the plasma membrane.
Positioning of the FCS detection volume on the upper membrane of
CHO-K1 cells transiently expressing either the full-length YFP-tagged
or the BiFC receptors resulted in time-dependent ﬂuorescence
ﬂuctuations (Fig. 4). Autocorrelation analysis of these ﬂuorescence
ﬂuctuations yielded a decay curve best ﬁt assuming two components
(Fig. 4C). We, and others, have previously shown that the faster
component, (τD1) which lies within the 50–100 μs range, most likely
represents an intramolecular photophysical process, such as blinking
of the YFP ﬂuorophore [20]. The slow-diffusing component (τD2)
represents the translational diffusion of the membrane-localised
YFP-fused A1R and A2AR. As shown in Table 1, both A1R and A2AR
homodimers (Fig. 5A and B) showed similar diffusion times when
expressed in CHO-K1 cells (τD2=14.5±1.5 ms and τD2=15.0 ±1.3 ms,
respectively) which are also similar to those described previously
[20]. The translational diffusion time observed for both the A1R and
A2AR homodimers did not signiﬁcantly differ from that measured for
the respective non YFP-complemented receptor (Table 1), suggesting
that homodimeric forms of the receptors exist in a similar membrane
environment to any monomers which are present. However, FCS
measurements indicated that the heterodimer formed by A1R and
A2AR (Fig. 5C) diffused signiﬁcantly faster than the A1RYFP, but not the
A2ARYFP (τD2=12.9±1.1 ms vs. τD2=18.0±1.1 ms for A1RYFP or
τD2=14.3±0.8 ms for A2ARYFP). This difference is unlikely to be due
to differences in the photophysical properties of the wtYFP vs. the
Fig. 4. FCSmeasurements of A1RYFP receptor diffusion. An illustration of the positioning of the detection volume for FCSmeasurement of the A1RYFP. (A) A live epi-ﬂuorescent image of
the chosen cell was used to localise the measurement volume in the × and y axes. (B) An intensity scan through the cell in the z-axis clearly demonstrates the position of lower and
upper cell membrane (LM/UM), and allows positioning of the detection volume on the upper membrane peak (dotted line, z-pos). (C) Fluorescence ﬂuctuations (top) are recorded
from the upper membrane, and the subsequent autocorrelation analysis shown (bottom) along with the residuals to the curve ﬁt. The indicated positions of τD1 (photophysical) and
τD2 (translational diffusion) components are shown. The ﬁtted values for the photophysical component (τD1) and translational diffusion (τD2) of the receptor population are shown,
along with their respective fractional contributions. The data shown are representative of measurements from 27 cells, with mean data as shown in Table 1. Similar data were
obtained for the A2ARYFP construct.
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constructs expressed freely in the cytosol was not found to be
different (161±14 and 179±10 μs, n=13, wtYFP and cYFP, respec-
tively). Interestingly, the number of particles (Nμm−2) of the τD2
component, which reﬂects the concentration of the receptors at the
plasma membrane, was signiﬁcantly lower for the A1R homodimers
and the heterodimers when compared to the total receptor
population (Table 1). However, it should be noted that this only
represents the detected receptors, and not those dimers which are
non-ﬂuorescent (e.g. N-YFP+N-YFP) and monomers. These results
suggest that heterodimers between the A1R and A2AR behave
differently in terms of their plasma diffusion than either receptorTable 1
Diffusion times of ﬂuorescently tagged adenosine receptors
Transfection τD2 (ms) D (×10−9 cm2/s) Nμm−2(τD2) N
A1RYFP 18.0±1.1 4.0±0.3 13.3±2.1 27
A2ARYFP 14.3±0.8 5.1±0.3 19.3±2.8 29
A1RN-YFP+A1RC-YFP 14.5±1.5 5.0±0.6 6.6±0.9⁎ 33
A2ARN-YFP+A2ARC-YFP 15.0±1.3 4.8±0.5 13.5±1.3† 34
A1RN-YFP+A2ARC-YFP 12.9±1.1⁎ 5.6±0.5⁎ 7.6±0.5⁎‡ 28
FCS measurements (30 s) were performed on the upper cell membrane of CHO-K1 cells
transiently transfected with the indicated constructs as described in Materials and
methods. Readings were taken using at identical laser powers in each case. Data were
ﬁtted in Zeiss AIM4.2 software, assuming two 2D diffusion components and a blinking
component. In each case, the ﬁrst diffusion component (τD1) represent photophysical
properties of the YFP label, and did not differ signiﬁcantly between constructs. The
component representing translational diffusion of the species (τD2) is shown, along
with the corresponding diffusion co-efﬁcient (D) to which this equates. The particle
(receptor) number (N) of the τD2 component is also shown. Results are shown asmean±s.e.
mean ofmeasurements from ‘n' cells measured in 3–4 independent transfections. Statistical
analysis was by one way ANOVA, with post-hoc Newman–Keul's test. ⁎Pb0.05 vs A1RYFP,
†Pb0.05 vs A1RN-YFP+A1RC-YFP, ‡Pb0.01 vs A2ARYFP.homodimers or monomers. This could reﬂect either their presence in
different membrane compartments or domains or possible differ-
ences in their interaction with other proteins, such as scaffolding
proteins or signalling partners.
4. Discussion
Determination of protein-protein interactions is an important step
in the study of a large number of cellular mechanisms. Oligomeriza-
tion of GPCRs is now a well-established phenomena which is thought
to result in functional entities which can differ in their biochemical
and pharmacological characteristics in comparison to the individual
components of the oligomer. Some of these characteristics can be used
as a “biochemical ﬁngerprint” to identify GPCR oligomers in vivo
which can potentially serve as targets for pharmacological interven-
tion in pathological conditions [7,25]. For instance, we have recently
demonstrated that the adenosine A1-A2A receptor heteromer acts as a
concentration-dependent switch that controls striatal glutamatergic
neurotransmission [26], thus this receptor heteromer provides a
rationale for the existence of oligomers of receptors for the same
neurotransmitter and demonstrates that neurotransmitter hetero-
mers composed of receptor subtypes with different afﬁnities for their
endogenous neurotransmitter and different signaling pathways can
act as concentration-dependent processors that exert a ﬁne-tune
modulation of neurotransmission [27].
Traditionally, some methods including co-immunolocalization,
and immobilized protein-protein interaction assays, such as co-
immunoprecipitation and GST pull-down have been used to initially
characterize such interactions. However, the invasive nature of these
approaches still has the disadvantage of removing the proteins of
interest form their natural environment within the cell and therefore
Fig. 5. FCS measurements of the diffusion of A1R and A2AR homodimers and A2AR-A1R heterodimers. FCS measurements were performed on the upper membrane of CHO-K1 cells
transiently expressing the indicated constructs. The detection volume was positioned in×and y using a live cell image, and subsequently in z using an intensity scan. Fluctuations
were recorded for 30 s following a 15 s pre-bleach in cells expressing either (A) A1RN-YFP+A1RC-YFP (B) A2ARN-YFP+A2ARC-YFP and (C) A1RN-YFP+A2ARC-YFP. In each case the recorded
ﬂuorescence ﬂuctuations (top) and subsequent autocorrelation analysis (middle) are shown along with residuals of the subsequent curve ﬁt (bottom). In each case the ﬁtted values
for the photophysical component (τD1) and translational diffusion (τD2) of the receptor population are shown, along with their respective fractional. Each experiment shown is
representative of 27–34 cells measured over 3–4 transfections.
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membrane proteins (e.g. GPCRs) due to their highly hydrophobic
organization and the need for detergents to extract them from
membranes. Nowadays, the use of light resonance-based methods in
the study of protein-protein interactions is extensively used, thus
allowing the study in living cells. Interestingly, these powerful
technical approaches have been also implemented in the study of
GPCRs oligomerization [9], thus helping to better understand the
protein-protein interactions occurring within a GPCR oligomer.
However, to date, we have not directly visualised A1–A2A receptor
dimers in cells, and in particular, the existence of homodimers of these
receptors is only inferred. The use of BiFC allows us to see directly
whether such oligomerisation of receptors occurs. Although it should
also be noted at this point that BiFC does not allow us to distinguish
between true dimers (i.e. two receptors) or higher order oligomers,
although use of molecular brightness techniques, such as photon
counting histogram analysis (PCH) of ﬂuctuation data may help in this
respect (see later). In this case, we have demonstrated that both A1R
and A2AR homodimers form and are expressed at the cell surface. The
cellular distribution of the oligomers is, in each case, not noticeably
different from that seen in the total population (i.e. tagged with
wtYFP). This suggests that either oligomers form a substantial part of
the total receptor population, or simply that monomers and oligomers
exist in the same cellular compartments. Interestingly, homo-
oligomers of both the A1R and A2AR were detected intracellulary, as
well as on the cell membrane, indicating that oligomer formation
occurs either prior to delivery to the membrane or following
trafﬁcking of the receptors from the membrane. BiFC also conﬁrmed
the formation of A1R–A2AR heterodimers in CHO-K1 cells. Again, these
were present predominantly on the cell surface, but also intracellu-
larly. We believe that the complementation seen in these CHO-K1 cells
is not simply due to random complementation events in the
membrane since we saw no such complementation where the
secondary partner was either another transmembrane receptor
(CD4) or a different GPCR (GABAB2).
Ultimately, the advantage of BiFC in this instance is to visually
isolate receptor oligomers form other forms, so that the properties ofthe oligomers can be studied in isolation. The high signal: noise ratio
of the BiFC approach, without the drawbacks of cross-talk or bleed-
through (which can be issue with FRET, for example), allows a
relatively low levels of expression to be used in these experiments. At
such expression levels, the sensitivity of FCS makes it a useful
technique to study the behaviour of these oligomers in the plasma
membrane. FCS, as well as other techniques such Fluorescence
Recovery After Photobleaching (FRAP) and Single Particle Tracking
(SPT), allow us to measure the diffusion co-efﬁcient of labelled GPCRs
in the cell membrane. FCS allows a direct quantiﬁcation of both dwell
time of the species within the detection volume (related to the
diffusion co-efﬁcient, D) and uniquely among these techniques,
particle (receptor) number. However, it must be noted that particle
number provides information on the number of diffusing species
rather than the number of molecules within a particular diffusing
complex. The dwell time obtained can be inﬂuenced by the mass of
the species of interest (it increases proportionally with the cube root
of Mr), its membrane environment or the number and properties of
interacting proteins such as cytoskeleton. One of the disadvantages of
FCS, however, is that, unlike FRAP, it gives no indication of immobile
receptor fraction and, unlike SPT, the data does not directly infer any
diffusion mode.
We, and others, have previously shown that FCS can provide
useful information about the diffusion of a ﬂuorescent protein
tagged GPCRs, as well as those labelled using ﬂuorescent ligand
approaches. This approach has shown, for example with the
bradykinin BK2 receptor [28] and complement C5a receptor [29],
that sub-populations of receptors with differing membrane mobi-
lities can be identiﬁed. Our data here indicates that using BiFC in
conjunction with FCS, the diffusion of wild type and homo-and
hetero-oligomeric forms of the A1R and A2AR can be determined in
CHO-K1 cells. The diffusion time of the A1RYFP is very similar to that
seen before for a Topaz-labelled version of the same receptor [20],
and equates to a diffusion co-efﬁcient (D) of (4.0±0.3)×10−9 cm2/s.
A similar value for the A2ARYFP was also found (5.1±0.3)×10−9 cm2/s.
Both are also similar to diffusion co-efﬁcients found for either
directly tagged GPCRs using FCS, and also transmembrane receptors
2268 S.J. Briddon et al. / Biochimica et Biophysica Acta 1783 (2008) 2262–2268of other superfamilies [14,28,29]. In each case, the diffusion co-
efﬁcent of the receptor homodimer did not show any signiﬁcant
difference from that of the total receptor population (as represented
by the wtYFP construct). This suggests that either the total
population consists of a high proportion of oligomeric species or
simply that the monomeric and dimeric species do not differ
signiﬁcantly in their membrane environment and organisation.
However, a small but signiﬁcant decrease in diffusion time (increase
in diffusion co-efﬁcient) was seen for the hetero-oligomer between
the A1R and the A2AR as compared to the wtYFP labelled-A1R
construct. This difference (approximately 20% change vs A1RYFP for
instance) equates to an approximate 2.5–3 fold change in molecular
mass or equivalent. These differences are not due to differences in
photophysical properties of the wtYFP and cYFP (e.g. photobleach-
ing), since ﬁrstly, under the same experimental conditions wtYFP
and cYFP showed the same diffusion times, and secondly this
difference was not found for the homodimeric species. Our results
provide no direct explanation for the reason behind this difference.
It could be that heterodimer formation leads to a localisation in a
membrane domain of differing viscosity to homodimer formation,
or a change in the associated signalling partner or scaffolding
protein. An alternative explanation is that the heterodimer exists in
a higher order oligomer (e.g. tetramer) whilst the homodimer exists
simply as a true dimeric species. Further experiments will be
necessary to ascertain this. The technique of photon counting
histogram analysis [30], which analyses ﬂuctuation data with
respect to molecular brightness, may be of particular use in this
respect, as a tetramer, for example, will show a doubling of
molecular brightness compared to a dimer.
In summary, the approach presented here, based on the
combination of BiFC and FCS techniques, permits the study of the
lateral mobility of ﬂuorescently isolated oligomeric proteins (e.g.
GPCRs) in living cells and should be a powerful tool for the
investigation of protein-protein interactions in vivo. Since FCS is
particularly suitable for use at low levels of receptor expression, this
also means that this combined BiFC/FCS approach may avoid some
the problems associated with the various resonance energy transfer
methodologies [31].
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